Abstract
Hepatitis C virus (HCV) infection among injecting drug users (IDUs) is a major public health concern. It is important to know the current burden of HCV infection among IDUs for targeted public health interventions in this high risk population. We systematically reviewed the published literature on prevalence of HCV infections among IDUs between January 1989 and April 2014. Sixty studies met the inclusion criteria for the review and subsequent analysis. Among the selected studies 26,311 IDUs were assessed for HCV infection of which 16,231 were positive, giving an overall prevalence of 61.7% (95% Confidence Interval [95% CI] 61.1-62.3%). Of the selected studies, 21 were from Asia, 20 from Europe, 13 from Americas, 5 from Australia and one from Africa. Combined regional estimates of HCV prevalence among IDUs showed that Africa has the highest mean prevalence of HCV among IDUs (97.3%, 95% CI 95.5-98.4%), however, this estimate was based only on one study from Mauritius. Europe has the second highest mean prevalence (65.9%, 95% CI 64.9-66.9%) followed by Australia (56.5%, 95% CI 53.8-59.2%). Our review suggests that the prevalence of HCV among IDUs is significantly high. There are very limited data from African nations. More comprehensive understanding of HCV epidemiology among IDUs including the risk behaviours are needed for this high risk group.
Keywords: Hepatitis C virus, intravenous drug user, prevalence study, risk behaviour, targeted public health intervention.
Infectious Disorders - Drug Targets
Title:Current Burden of Hepatitis C Virus Infection Among Injecting Drug Users: A Mini Systematic Review of Prevalence Studies
Volume: 14 Issue: 2
Author(s): Shafquat Mohammed Rafiq, Gouri Rani Banik, Sabina Khan, Harunor Rashid and Gulam Khandaker
Affiliation:
Keywords: Hepatitis C virus, intravenous drug user, prevalence study, risk behaviour, targeted public health intervention.
Abstract: Hepatitis C virus (HCV) infection among injecting drug users (IDUs) is a major public health concern. It is important to know the current burden of HCV infection among IDUs for targeted public health interventions in this high risk population. We systematically reviewed the published literature on prevalence of HCV infections among IDUs between January 1989 and April 2014. Sixty studies met the inclusion criteria for the review and subsequent analysis. Among the selected studies 26,311 IDUs were assessed for HCV infection of which 16,231 were positive, giving an overall prevalence of 61.7% (95% Confidence Interval [95% CI] 61.1-62.3%). Of the selected studies, 21 were from Asia, 20 from Europe, 13 from Americas, 5 from Australia and one from Africa. Combined regional estimates of HCV prevalence among IDUs showed that Africa has the highest mean prevalence of HCV among IDUs (97.3%, 95% CI 95.5-98.4%), however, this estimate was based only on one study from Mauritius. Europe has the second highest mean prevalence (65.9%, 95% CI 64.9-66.9%) followed by Australia (56.5%, 95% CI 53.8-59.2%). Our review suggests that the prevalence of HCV among IDUs is significantly high. There are very limited data from African nations. More comprehensive understanding of HCV epidemiology among IDUs including the risk behaviours are needed for this high risk group.
Export Options
About this article
Cite this article as:
Rafiq Shafquat Mohammed, Banik Gouri Rani, Khan Sabina, Rashid Harunor and Khandaker Gulam, Current Burden of Hepatitis C Virus Infection Among Injecting Drug Users: A Mini Systematic Review of Prevalence Studies, Infectious Disorders - Drug Targets 2014; 14 (2) . https://dx.doi.org/10.2174/1871526514666141014145612
DOI https://dx.doi.org/10.2174/1871526514666141014145612 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroprotective Effects of Extracts from the Radix Curcuma aromatica on H2O2-induced Damage in PC12 Cells
Combinatorial Chemistry & High Throughput Screening Antioxidant, Xanthine Oxidase and Monoamine Oxidase Inhibitory Potential of Coumarins: A Review
Current Organic Chemistry Neurotrophic Factors in the Pathogenesis of Neurological Disorders with Mental Retardation in Children
Current Pediatric Reviews Editorial from Guest Editor [Hot Topic:Animal Venoms: From Deadly Arsenals (Toxins) to Therapeutic Drug Candidates (Guest Editor: Jean-Marc Sabatier)]
Inflammation & Allergy - Drug Targets (Discontinued) Circadian Rhythms, Melatonin and Depression
Current Pharmaceutical Design Leptin Induces Neuroprotection Neurogenesis and Angiogenesis after Stroke
Current Neurovascular Research Palmitoylethanolamide Regulates Production of Pro-Angiogenic Mediators in a Model of β Amyloid-Induced Astrogliosis <i>In Vitro</i>
CNS & Neurological Disorders - Drug Targets Editorial [Hot Topic: Expanding Knowledge on Protein Misfolding: Unravelling the Molecular Basis of Neurodegeneration (Guest Editor: Rosana Chehin)]
Current Protein & Peptide Science Modulation of the TRPV1 Channel: Current Clinical Trials and Recent Patents with Focus on Neurological Conditions
Recent Patents on CNS Drug Discovery (Discontinued) Wnt Signaling in Development, Disease and Translational Medicine
Current Drug Targets Patent on Biomarkers in Medical Research: A Focus on Neuropsychiatric Disorders
Recent Patents on Biomarkers The Possible Involvement of HLA Class III Haplotype (RAGE, HSP70 and TNF Genes) in Alzheimer's Disease
Current Alzheimer Research Alzheimer’s Disease Biomarkers and Epigenetic Intermediates Following Exposure to Pb In Vitro
Current Alzheimer Research Third and Fourth Generation Fluoroquinolone Antibacterials: A Systematic Review of Safety and Toxicity Profiles
Current Drug Safety <i>Arthrophytum scoparium</i> Extract Improves Memory Impairment and Affects Acetylcholinesterase Activity In Mice Brain
Current Pharmaceutical Biotechnology Transgenic Mouse Models of Tauopathy in Drug Discovery
CNS & Neurological Disorders - Drug Targets Stem Cell-Based Approaches for Intervertebral Disc Regeneration
Current Stem Cell Research & Therapy Editorial [Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement. PART I. (Executive Editors: Calogero Caruso Thea Magrone and Emilio Jirilllo)]
Current Pharmaceutical Design The Classic Basic Protein of Myelin – Conserved Structural Motifs and the Dynamic Molecular Barcode Involved in Membrane Adhesion and Protein-Protein Interactions
Current Protein & Peptide Science Nanostructured Lipid Carriers (NLCs) for Drug Delivery: Role of Liquid Lipid (Oil)
Current Drug Delivery